Clinical and pathogenetic aspects of abamectin poisoning in calves;Aspectos clínicos e patogenéticos da intoxicação por abamectina em bezerros

Pesquisa Veterinaria Brasileira

Volumn 26, Issue 3, 2006, Pages 161-166

  Seixas, Josilene N ^a   Peixoto, Paulo V ^a   Armién, Anibal G ^b   Jabour, Flávia F ^a   Brito, Marilene F ^a  

^a FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Abamectin poisoning; Calves; Neurological alterations

Indexed keywords

BOS TAURUS;

EID: 33749506042     PISSN: 0100736X     EISSN: 0100736X     Source Type: Journal    
DOI: 10.1590/s0100-736x2006000300006     Document Type: Article

References (29)

1. a ed. Roca, SP.
2. a ed. Guanabara Koogan, Rio de Janeiro.
3. Barbosa J.D.N. 2004. Comunicação pessoal (Clínica de Animais de Grande Porte, Universidade Federal do Pará, PA).
4. Barragry T.B. 1994. Clinical pharmacology of endoparasiticides, p.104-110. In: Ibid. (ed.) Veterinary Drug Therapy. Lea & Febiger, Philadelphia.
5. Basílio J. 2005. A revolucionária descoberta. Disponível em:〈http://www.vaquejadas.com./index.php?fa.mat. infmateria&mat_id=1168〉. Acesso em: 08 fev. 2005.
6. Benz G.W. & Cox J.L. 1989. Use of abamectin in cattle, p.230-233. In: Campbell W.C. (ed.) Ivermectin and Abamectin. Springer Verlag, New York.
7. Burg R.W., Miller B.M., Baker E.E., Birnbaum J., Currie S.A., Hartman R., Kong Y.L., Monaghan R.L., Olson G., Putter I., Tunac J.B., Wallick H., Stapley E.O., Oiwa R. & Omura S. 1979. Avermectins, new family of potent anthelmintic agents: producting organism and fermentation. Antimicrob Agents Chemother. 15:361-367.
8. Button C., Barton R., Honey P. & Rickford P. 1988. Avermectin toxicity in calves and an evaluation of picrotoxin as an antidote. Aust. Vet. J. 65:157-158. (Cit. Pulliam & Preston 1989)
9. Chabala J.C., Mrozik H., Tolman R.L. Eskola P., Lusi A., Peterson L.H., Woods M. F. & Fisher M.H. 1980. Ivermectin, a new broad-spectrum antiparasitic agent. J. Med. Chemist. 23:1134-1336.
10. Corwin R. M. 1999. Special therapy, Anthelmintic therapy, p.34-35. In: Howard J.M. & Smith R.A. (ed.) Current Veterinary Therapy, Food Animal Pratice. 4th ed. W.B. Saunders, Philadelphia.
11. Courtney C.H. & Roberson E.L. 1995. Chemotherapy of parasitic disease. Antinematodal drugs, p.916-922. In: Adams H.R. (ed.) Veterinary Pharmacology and Therapeutics. 7th ed. Iowa State University Press, Ames.
12. Driemeier D. 2001. Comunicação pessoal (Departamento de Patologia Clínica Veterinária, Setor de Patologia Veterinária, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS).
13. Fisher M.H. & Mrozik H. 1989. Chemistry, p.1-23. In: Campbell W.C. (ed.) Ivermectin and Abamectin. Springer Verlag, New York.
14. Forbes A.B. 1993. A review of regional and temporal use of avermectinas in cattle and horses worldwide. Vet. Parasitol. 48:19-28.
15. Lankas G.R. & Gordon L.R. 1989. Toxicology, p.89-112. In: Campbell W.C. (ed.) Ivermectin and Abamectin. Springer Verlag, New York.
16. Lankas G.R., Cartwright M.E. & Umbenhauer D. 1997. P-glicoprotein deficiency in a subpopulação of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol. Appl. Pharmacol. 143:357-365.
17. Moore L.F. 1999. Dermatologic disease. External parasites, p.731. In: Corviw R.M. (ed.) Current Veterinary Therapy, Food Animal Pratice. 4th ed. W.B. Saunders, Philadelphia.
18. Nobmann S., Bauer B. & Fricker G. 2001. Ivermectin excretion by isolates functionally intact brain endothelial capillaries. Brit. J. Pharmacol. 132:722-728.
19. Oliveira C.M. 2004. Comunicação pessoal (Clínica de Animais de Grande Porte, Universidade Federal do Pará, Castanhal, PA).
20. Payne G.T. & Soderlund D.M. 1993. Actions os avermectina analogues on ã-aminobutyric acid (GABA)-sensitive and GABA-insensitive chloride channels in mouse brain. Pestic. Bioch. Physiol. 47:178-184.
21. Pulliam J.D. & Preston J.M. 1989. Safety of ivermectin in target animals, p.149-161. In: Campbell W.C. (ed.) Ivermectin and Abamectin. Springer Verlag, New York.
22. Radostits O.M., Gay C.C., Blood D.C. & Hinchcliff K.W. 2002. Doenças causadas por substâncias químicas inorgânicas e produtos químicos utilizados nas fazendas, p.1417-1471. In: Ibid. (ed.) Clínica Veterinária: um tratado de doenças dos bovinos, ovinos, suínos, caprinos e eqüinos. 9a ed. Guanabara Koogan, Rio de Janeiro.
23. Riet-Correa F. 2006. Comunicação pessoal (Hospital Veterinário do Centro de Saúde e Tecnologia Rural, Universidade Federal de Campina Grande, Patos, PB).
24. Silva E.C. 2002. Neurotransmissão aminérgica central, p.287-301. In: Silva P. (ed.) Farmacologia. 6a ed. Guanabara Koogan, Rio de Janeiro.
25. Steel J.W. 1993. Pharmacokinetics and metabolism of avermectins in livestock. Vet. Parasitol. 48:45-57.
26. Taylor M.A. 2001. Review: recent developments in ectoparasites. Vet. J. 161:253-268.
27. Tracy J.M. & Webster L. T. Jr. 2001. Drugs used in the chemotherapy of helminthiasis, p.1131-1133. In: Harman J.G., Limbird L.E & Gilman G.A. (ed.) Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. Internacional Edition, New York.
28. Turner M.J. & Schaeffer J.M. 1989. Mode of action of ivermectin, p.73-88. In: Campbell W.C. (ed.) Ivermectin and Abamectin. Springer Verlag, New York.
29. Wouters F. 2005. Comunicação pessoal (Departamento de Medicina Veterinária, Universidade Federal de Lavras, MG).